Medical providers are often asked by their kidney recipients and donors about what to do or to avoid. Common questions include medications, diet, isolation, return to work or school, pregnancy, fasting Ramadan, or hajj and Omrah. However, there is only scant information about these in English language and none in Arabic. Here, we present evidence-based education materials for medical providers (in English language) and for patients and donors (in Arabic language). These educational materials are prepared to be easy to print or adopt by patients, providers, and centers.
INSTRUCTIONS FOR KIDNEY GRAFT RECIPIENTS (PROVIDERS' INFORMATION)
1. Medications:
• Immunosuppression medications: -These medications are to protect against rejection of the transplanted kidney. -These medications include tacrolimus (Prograf or FK) and mycophenolate mofetil (MMF) (CellCept) and prednisolone. -These medications are to be maintained for the life of the graft. -Stopping these medications will lead to rejection and possibly loss of the graft. -These medications must be taken at the exact time prescribed by your doctor. • Prophylactic antimicrobial medications: -These medications are to decrease the risk of opportunistic viral, bacterial, and fungal infections.
-These medications include valganciclovir (Valgan), nystatin, and Bactrim. [1, 2] 
Medication side effects:
Tacrolimus (Prograf or FK) may cause diabetes, hypertension, alopecia, tremor, and renal insufficiency. MMF (CellCept) may cause low white blood count. Prednisolone may cause high blood sugar. [1] [2] [3] 
Clinic follow-up and laboratory testing:
-You need to keep your appointments for clinic visits and laboratory testing. -Do not take tacrolimus (Prograf or FK) in the morning of your labs but take it right away after the blood draw. -Remember to have an appointment for the stent removal, which is typically removed by urologist in • MMF is teratogenic and should be stopped or replaced with azathioprine before pregnancy is attempted (allow 12 weeks window before contemplating pregnancy after switching from MMF to AZA). • mTORi should be discontinued before pregnancy is attempted. • Angiotensin converting enzyme inhibitors (ACE) / angiotensin-receptor blockers (ARBs) should be discontinued or replaced with other class of medication during pregnancy. • Calcineurin inhibitor, prednisone, and AZA are generally safe during pregnancy. -Delivery in transplanted patient can be through vaginal route if there is no indication for cesarian section. [1, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] 
Vaccinations: Yearly vaccination against flu (inactive)
is highly recommended. Pneumonia vaccination is also recommended. 17. Signs and symptoms of rejection: There are no specific signs or symptoms for rejection in most of the cases. Blood tests are the only ways to find out. Patients are strongly advised to adhere to their medications and their routinely scheduled laboratory tests. In early stages decreased urine output, fever, vomiting, pain at the site of the graft or lathery can appear in late stages. 18. You must report to the emergency room in case of fever, decreased amount of urine, vomiting, inability to take medications, or not feeling well in general [ Tables 1 and 2 ].
INSTRUCTIONS FOR KIDNEY DONORS (PROVIDERS' INFORMATION)
1. Work: You can return to work once the surgical pain resolves (after 1-2 months). Please consult with your surgeon. Tables 3 and 4 ]. [1, 69, 70] Disclaimer: This educational material was designed to aid the renal transplant team to provide written educational material to their renal transplant recipients. This document should not be construed as dictating exclusive courses of recommendations. Patients are advised to consult with their health providers for more specific advice. Variations from these educational materials may be warranted in actual practice based on individual patient characteristics and clinical judgment in unique care circumstances.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. 
